(Q41945223)

14 October 2017

Effect of nadolol on liver haemodynamics and function in patients with cirrhosis (English)

1 reference

14 October 2017

1 reference

Merkel C

1

1 reference

14 October 2017

Sacerdoti D

2

1 reference

14 October 2017

Finucci GF

3

1 reference

14 October 2017

Zuin R

4

1 reference

14 October 2017

Bazzerla G

5

1 reference

14 October 2017

Bolognesi M

6

1 reference

14 October 2017

Gatta A

7

1 reference

14 October 2017

language of work or name

English

0 references

publication date

1 June 1986

1 reference

British Journal of Clinical Pharmacology

14 October 2017

1 reference

14 October 2017

21

1 reference

14 October 2017

6

1 reference

14 October 2017

713-719

1 reference

The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study.

14 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400973

Selective and non-selective beta receptor blockade in the reduction of portal pressure in patients with cirrhosis and portal hypertension

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400973

Precipitation of hepatic encephalopathy by propranolol in cirrhosis

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400973

Effect of propranolol on hepatic blood flow in patients with cirrhosis.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400973

Commentary: a physiological approach to hepatic drug clearance

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400973

The Influence of Vasoactive Agents on Metabolic Activity of the Liver in Cirrhosis: A Study of the Effects of Posterior Pituitary Extract, Vasopressin, and Somatostatin

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400973

Kinetics of CO2-HCO3 minus in normal adult males

18 August 2018

1 reference

12 December 2020

Determination of the hepatic galactose elimination capacity after a single intravenous injection in man: the reproducibility and the influence of uneven distribution

1 reference

12 December 2020

Quantitative Assessment of Hepatic Function by Breath Analysis after Oral Administration of [^14C]aminopyrine

1 reference

12 December 2020

Mechanism for reduced drug clearance in patients with cirrhosis

1 reference

12 December 2020

Effect of sinusoidal perfusion on galactose elimination kinetics in perfused rat liver

1 reference

12 December 2020

Intrinsic hepatic clearance in cirrhosis

1 reference

12 December 2020

Effect of propranolol on hepatic blood flow in normal and portal hypertensive rats

1 reference

12 December 2020

Preserved Renal Perfusion During Treatment of Essential Hypertension with the Beta Blocker Nadolol

1 reference

12 December 2020

Propranolol increases arterial ammonia in liver cirrhosis

1 reference

12 December 2020

Effects of nadolol treatment on renal and hepatic hemodynamics and function in cirrhotic patients with portal hypertension

1 reference

12 December 2020

Effect of somatostatin on splanchnic hemodynamics in patients with liver cirrhosis and portal hypertension

1 reference

12 December 2020

The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function

1 reference

12 December 2020

Esophageal varices, splenic pulp pressure and "directional" flow patterns in alcoholic liver cirrhosis

1 reference

12 December 2020

10.1111/J.1365-2125.1986.TB05237.X

Identifiers

DOI

1 reference

14 October 2017

1 reference

14 October 2017

PubMed publication ID

3741719

1 reference